Zai Lab to Seek China Approval for Cervical Cancer Therapy After Positive Trial Data
Li Auto Achieves 200,000 Units Of Li L6 SUV Production: Report
Indaptus Therapeutics Provides 2025 Outlook, Launching Decoy20 Combination Cohort With BeiGene's Tislelizumab, Expanding Clinical Sites Beyond 8, Updating Higher Dose Cohort, First Patient Dosed In Combination, Focus On Cancer Challenges
What the Options Market Tells Us About Alibaba Gr Hldgs
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
Express News | FTSE China A50 Index Futures Surge Over 1%; Pinduoduo Nearly 5% Premarket